跳至主要内容
临床试验/ACTRN12612000570886
ACTRN12612000570886招募中2 期

In children aged 2-16 with moderate to severe atopic dermatitis (eczema), is daily vitamin D3 (1000 IU/day) more effective than placebo in improving the severity of the eczema and quality of life.

Prof Dianne Campbell0 个研究点目标入组 150 人开始时间: 2012年5月28日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
2 Years 至 16 Years(—)
性别
All

入选标准

  • Inclusion criteria-
  • Atopic dermatitis consistent with diagnostic criteria of Hanifin and Rajka.
  • Ages- 2 years- 16 years
  • Moderate-severe eczema at study entry defined as an objective SCORAD of > 15 (0-83)

排除标准

  • Exclusion Criteria
  • Ages <2 years or >16 years
  • Past or current history of oral immunosuppression therapy (Cyclosporin, Azathioprine, Methotrexate)
  • Oral corticosteroids < 6 months prior to study
  • IVIg therapy< 2 years prior to study
  • Hypercalcaemia, Hypertension, Anticonvulsant therapy

研究者

发起方
Prof Dianne Campbell

相似试验